Literature DB >> 18076926

Robotic simple prostatectomy.

Rene Sotelo1, Rafael Clavijo, Oswaldo Carmona, Alejandro Garcia, Eduardo Banda, Marcelo Miranda, Randy Fagin.   

Abstract

PURPOSE: Minimally invasive approaches for large, symptomatic benign prostatic hyperplasia are replacing the gold standard open surgical approach, duplicating its results with lower morbidity. We describe our initial experience with robotic simple prostatectomy.
MATERIALS AND METHODS: Since January 2007, robotic simple prostatectomy was performed via a transperitoneal approach in 7 patients with symptomatic significant prostatomegaly on transrectal ultrasound (mean 77.66 gm). Demographic, perioperative and outcome data were recorded and all procedures were performed by the same surgeon.
RESULTS: Average patient age was 63.2 years (range 56 to 72) and estimated blood loss was 298 ml (range 60 to 800). Average operative time was 205 minutes (range 120 to 300). Average hospital stay was 1.4 days (range 1 to 2), average Foley catheter duration was 7 days (range 6 to 9) and drains were removed after an average of 3.75 days (range 3 to 4). Mean specimen weight on pathological examination was 50.48 gm (range 40 to 64.5). Transfusion was necessary in 1 patient. No complications were documented. Considerable improvement from baseline was noted in International Prostate Symptom Score (preoperative vs postoperative 22 vs 7.25) and maximum urine flow (preoperative vs postoperative 17.75 vs 55.5 ml per minute). Four patients were in acute urinary retention preoperatively.
CONCLUSIONS: Robotic simple prostatectomy is a feasible, reproducible procedure. Further publications are expected with larger series and larger prostatic adenomas.

Entities:  

Mesh:

Year:  2008        PMID: 18076926     DOI: 10.1016/j.juro.2007.09.065

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  43 in total

1.  Surgical treatment of large volume prostates: a matched pair analysis comparing the open, endoscopic (ThuVEP) and robotic approach.

Authors:  Sebastian Nestler; T Bach; T Herrmann; S Jutzi; F C Roos; C Hampel; J W Thüroff; C Thomas; A Neisius
Journal:  World J Urol       Date:  2018-12-04       Impact factor: 4.226

2.  Recent advances in the surgical treatment of benign prostatic hyperplasia.

Authors:  Bernardo Rocco; Giancarlo Albo; Rafael Coelho Ferreira; Matteo Spinelli; Gabriele Cozzi; Paolo Dell'orto; Vipul Patel; Francesco Rocco
Journal:  Ther Adv Urol       Date:  2011-12

3.  Robotic-assisted laparoscopic simple prostatectomy: an alternative minimal invasive approach for prostate adenoma.

Authors:  Ekong E Uffort; James C Jensen
Journal:  J Robot Surg       Date:  2010-04-01

4.  Robotic-assisted laparoscopic simple prostatectomy and bladder diverticulectomy with temporary clamping of internal iliac arteries.

Authors:  F Sergi; C Falavolti; A M Bove; M Buscarini
Journal:  J Robot Surg       Date:  2013-01-10

5.  From open simple to robotic-assisted simple prostatectomy (RASP) for large benign prostate hyperplasia: the time has come.

Authors:  H John; Ch Wagner; Ch Padevit; J H Witt
Journal:  World J Urol       Date:  2021-02-11       Impact factor: 4.226

6.  [Long-term results after robot-assisted adenoma enucleation].

Authors:  A Häcker; J W Thüroff
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

Review 7.  Robot-Assisted Simple Prostatectomy: Expanding on an Established Operative Approach.

Authors:  Ross Cockrell; David I Lee
Journal:  Curr Urol Rep       Date:  2017-05       Impact factor: 3.092

8.  Management of Obstructive Benign Prostatic Hyperplasia With a >200 mL Gland.

Authors:  Christopher E Kelly
Journal:  Rev Urol       Date:  2018

Review 9.  Robotic-assisted simple prostatectomy: is there evidence to go beyond the experimental stage?

Authors:  Nishant D Patel; J Kellogg Parsons
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

10.  The en-bloc no-touch holmium laser enucleation of the prostate (HoLEP) technique.

Authors:  Cesare Marco Scoffone; Cecilia Maria Cracco
Journal:  World J Urol       Date:  2015-12-11       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.